Exane Derivatives Cognyte Software Ltd. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Cognyte Software Ltd. stock. As of the latest transaction made, Exane Derivatives holds 10 shares of CGNT stock, worth $87. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 10
-0.0%
Holding current value
$87
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CGNT
# of Institutions
124Shares Held
38.8MCall Options Held
395KPut Options Held
908K-
American Capital Management Inc New York, NY6.4MShares$56.1 Million1.43% of portfolio
-
Edenbrook Capital, LLC Mount Kisco, NY6.28MShares$55 Million18.06% of portfolio
-
Neuberger Berman Group LLC New York, NY5.29MShares$46.3 Million0.03% of portfolio
-
Acadian Asset Management LLC Boston, MA2.69MShares$23.6 Million0.06% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.68MShares$23.4 Million0.05% of portfolio
About Cognyte Software Ltd.
- Ticker CGNT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 67,860,400
- Market Cap $594M
- Description
- Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source a...